Breakthrough HIV jab arrives in 6 weeks, but cuts cripple rollout capacity
News24 | 23.04.2026 09:45
South Africa’s uptake of the once-every-six-months HIV prevention jab, lenacapavir (LEN), will be heavily affected by the Trump administration’s funding cuts to the country because they destroyed much of the infrastructure – such as community-based testing and field recruitment for HIV prevention services – needed to create demand for the medicine.
